Omnicell, Inc. PE Ratio 2010-2024 | OMCL

Current and historical p/e ratio for Omnicell, Inc. (OMCL) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Omnicell, Inc. PE ratio as of February 21, 2025 is 40.12.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Omnicell, Inc. PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-21 39.72 147.11
2024-12-31 44.52 $0.27 164.89
2024-09-30 43.60 $-0.39 0.00
2024-06-30 27.07 $-0.46 0.00
2024-03-31 29.23 $-0.46 0.00
2023-12-31 37.63 $-0.45 0.00
2023-09-30 45.04 $-0.77 0.00
2023-06-30 73.67 $-0.52 0.00
2023-03-31 58.67 $-0.40 0.00
2022-12-31 50.42 $0.10 504.20
2022-09-30 87.03 $1.02 85.32
2022-06-30 113.75 $1.26 90.28
2022-03-31 129.49 $1.49 86.91
2021-12-31 180.44 $1.62 111.38
2021-09-30 148.43 $1.71 86.80
2021-06-30 151.45 $1.30 116.50
2021-03-31 129.87 $0.77 168.66
2020-12-31 120.02 $0.73 164.41
2020-09-30 74.66 $0.87 85.82
2020-06-30 70.62 $1.13 62.50
2020-03-31 65.58 $1.60 40.99
2019-12-31 81.72 $1.42 57.55
2019-09-30 72.27 $1.27 56.91
2019-06-30 86.03 $1.14 75.46
2019-03-31 80.84 $0.93 86.92
2018-12-31 61.24 $0.92 66.57
2018-09-30 71.90 $1.18 60.93
2018-06-30 52.45 $1.01 51.93
2018-03-31 43.40 $0.87 49.89
2017-12-31 48.50 $0.51 95.10
2017-09-30 51.05 $-0.11 0.00
2017-06-30 43.10 $-0.22 0.00
2017-03-31 40.65 $-0.27 0.00
2016-12-31 33.90 $0.01 3390.00
2016-09-30 38.30 $0.22 174.09
2016-06-30 34.23 $0.39 87.77
2016-03-31 27.87 $0.66 42.23
2015-12-31 31.08 $0.84 37.00
2015-09-30 31.10 $0.88 35.34
2015-06-30 37.71 $0.86 43.85
2015-03-31 35.10 $0.83 42.29
2014-12-31 33.12 $0.83 39.90
2014-09-30 27.33 $0.77 35.49
2014-06-30 28.71 $0.78 36.81
2014-03-31 28.62 $0.74 38.68
2013-12-31 25.53 $0.67 38.10
2013-09-30 23.68 $0.64 37.00
2013-06-30 20.55 $0.63 32.62
2013-03-31 18.88 $0.50 37.76
2012-12-31 14.87 $0.47 31.64
2012-09-30 13.90 $0.43 32.33
2012-06-30 14.64 $0.32 45.75
2012-03-31 15.21 $0.36 42.25
2011-12-31 16.52 $0.31 53.29
2011-09-30 13.78 $0.21 65.62
2011-06-30 15.59 $0.16 97.44
2011-03-31 15.24 $0.14 108.86
2010-12-31 14.45 $0.15 96.33
2010-09-30 13.08 $0.15 87.20
2010-06-30 11.69 $0.14 83.50
2010-03-31 14.03 $0.11 127.55
2009-12-31 11.69 $0.02 584.50
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $1.840B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems Inc. (VEEV) US $36.657B 54.02
Hims & Hers Health, Inc. (HIMS) US $10.767B 273.78
Tempus AI, Inc. (TEM) US $10.720B 0.00
Inspire Medical Systems, Inc. (INSP) US $5.261B 102.50
iRhythm Technologies (IRTC) US $3.752B 0.00
Privia Health Group, Inc. (PRVA) US $2.942B 245.20
Enovis Corporation (ENOV) US $2.428B 16.18
Clover Health Investments, Corp. (CLOV) US $2.205B 0.00
Azenta, Inc. (AZTA) US $2.045B 95.21
Schrodinger, Inc. (SDGR) US $1.650B 0.00
Phreesia, Inc. (PHR) US $1.640B 0.00
10x Genomics (TXG) US $1.333B 0.00
Butterfly Network, Inc. (BFLY) US $0.916B 0.00
Talkspace, Inc. (TALK) US $0.508B 300.50
Fulgent Genetics, Inc. (FLGT) US $0.503B 0.00
Standard BioTools Inc. (LAB) US $0.484B 0.00
TruBridge, Inc. (TBRG) US $0.422B 122.87
Pulmonx Corporation (LUNG) US $0.354B 0.00
Nyxoah SA (NYXH) BE $0.352B 0.00
Health Catalyst, Inc. (HCAT) US $0.318B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.266B 0.00
American Well Corporation (AMWL) US $0.183B 0.00
EUDA Health Holdings Limited (EUDA) SG $0.098B 0.00
MDxHealth SA (MDXH) BE $0.088B 0.00
P3 Health Partners Inc. (PIII) US $0.075B 0.00
111, Inc. Sponsored ADR (YI) CN $0.072B 0.00
CareCloud, Inc. (CCLD) US $0.058B 0.00
HeartBeam, Inc. (BEAT) US $0.055B 0.00
Outset Medical, Inc. (OM) US $0.047B 0.00
Zepp Health Corporation Sponsored ADR (ZEPP) CN $0.045B 0.00
SHL Telemedicine Ltd. Unsponsored ADR (SHLT) IL $0.038B 0.00
Zhongchao Inc. (ZCMD) CN $0.035B 0.00
Movano Inc. (MOVE) US $0.033B 0.00
Bullfrog AI Holdings Inc. (BFRG) US $0.025B 0.00
MSP Recovery, Inc. (MSPR) US $0.016B 0.00
Streamline Health Solutions, Inc. (STRM) US $0.015B 0.00
Precipio, Inc. (PRPO) US $0.015B 0.00
ImmunoPrecise Antibodies Ltd. (IPA) CA $0.012B 0.00
Mobile-health Network Solutions (MNDR) SG $0.012B 0.00
Strata Skin Sciences, Inc. (SSKN) US $0.011B 0.00
Predictive Oncology Inc. (POAI) US $0.010B 0.00
Syra Health Corp. (SYRA) US $0.005B 0.00
Tivic Health Systems, Inc. (TIVC) US $0.004B 0.00
HeartSciences Inc. (HSCS) US $0.004B 0.00
Healthcare Triangle, Inc. (HCTI) US $0.003B 0.00
Future Health ESG Corp. (FHLT) US $0.000B 0.00